The fetal/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn

Neurology

Volumn 48, Issue 1, 1997, Pages 50-54

  Gardnerova, Miriam ^a,g   Eymard, B ^c   Morel, E ^b   Faltin, M ^a   Zajac, J ^a   Sadovsky, O ^d   Tripon, P ^e   Domergue, M ^f   Vernet Der Garabedian, B ^b   Bach, J F ^b  

^a IV Interna Klinika   (Slovakia)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d NsP Akademika Dérera   (Slovakia)

^e SERVICE D ENDOCRINOLOGIE   (France)

^f Maternité de Port Royal ^*  (France)

^g NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; DIAGNOSTIC VALUE; FETOMATERNAL TRANSFUSION; HUMAN; MYASTHENIA GRAVIS; NEWBORN; PREGNANCY; PRIORITY JOURNAL;

EID: 0031037405     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.1.50     Document Type: Article

References (31)

1. Papazian O. Transient neonatal myasthenia gravis. J Child Neurol 1992;7:135-141.
2. Morel E, Eymard B, Vernet-der Garabedian B, Pannier C, Dulac O, Bach JF. Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases. Neurology 1988;38: 138-142.
3. Bartoccioni E, Evoli A, Casali C, Scoppetta C, Tonali P, Provenzano C. Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants. J Neuroimmunol 1986;12:155-161.
4. Eymard B, Morel E, Moutard-Coudou ML, et al. Myasthénie et grossesse: une étude clinique et immunologique de 42 cas. Rev Neurol (Paris) 1989;145:696-701.
5. Stoll C, Ehret-Mentre MC, Treisser A, Tranchant C. Prenatal diagnosis of congenital myasthenia with artropogryposis in a myasthenic mother. Prenat Diagn 1991;11:17-22.
6. Tranchant C, Ehret C, Labouret P, Gasser B, Warter JM. Arthrogrypose et myasthénie maternelle. Risque de récurence. Rev Neurol (Paris) 1991;147:63-64.
7. Ohta M, Matsuraba F, Hayashi K, Nakao K, Nishitani H. Acetylcholine receptor antibodies in infants of mothers with myasthenia gravis. Neurology 1981;31:1019-1022.
8. Lefvert AK, Osterman PO. Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children. Neurology 1983;33:133-138.
9. Eymard B, Vernet-der Garabedian B, Berrih-Aknin S, Pannier C, Bach JF, Morel E. Anti-acetylcholine receptor antibodies in neonatal myasthenia gravis: heterogeneity and pathogenic significance. J Autoimmun 1991;4:185-195.
10. Tzartos SJ, Efthimiadis A, Morel E, Eymard B, Bach JF. Neonatal myasthenia gravis: antigenic specificities of antibodies in sera from mothers and their infants. Clin Exp Immunol 1990;80:376-380.
11. Keesey K, Lindstrom J, Cokely H, Hermann C. Anti-acetylcholine receptor antibody in neonatal myasthenia gravis. N Engl J Med 1977;296:55.
12. Mishina M, Takai T, Imoto K, et al. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 1986;321:406-411.
13. Witzemann V, Barg B, Criado M, Stein E, Sakmann B. Developmental regulation of five specific mRNAs encoding acetylcholine receptor subtypes in rat muscle. FEBS Lett 1989;242: 419-424.
14. Brenner HR, Witzemann V, Sakmann B. Imprinting of acetylcholine receptor messenger RNA accumulation in mammalian neuromuscular synapses. Nature 1990;344:544-547.
15. Galzi JL, Revah F, Bessis A, Changeux JP. Functional architecture of the nicotinic acetylcholine receptor: from electric-organ to brain. Annu Rev Pharmacol Toxicol 1991:31:37-72.
16. Karlin A. Explorations of the nicotinic acetylcholine receptor. Harvey Lect 1991;85:71-107.
17. Weinberg CB, Hall ZW. Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors. Proc Natl Acad Sci USA 1979; 76:504-508.
18. Dwyer SD, Bradley J, Furner RL, Kemp GE. Immunochemical properties of junctional and extrajunctional acetylcholine receptors. Brain Res 1981;217:23-40.
19. Souroujon MC, Pizzighella S, Mochly-Rosen D, Fuchs S. Antigenic specificity of acetylcholine receptor in developing muscle. Studies with monoclonal antibodies. J Neuroimmunol 1985;8:159-166.
20. Lennon VA, Griesma GE. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis. Neurology 1989;39:1069-1076.
21. Schuetze SM, Vicini S, Hall ZW. Myasthenic serum selectively blocks acetylcholine receptors with long channel open times at developing rat endplates. Proc Natl Acad Sci USA 1985;82: 2533-2537.
22. Lotwick H, Harrison R, Lunt G, Behan P. Interaction of fetal and adult human acetylcholine receptors with serum from patients with myasthenia gravis. J Neuroimmunol 1983;4: 167-174.
23. Vernet-der Garabedian B, Lacokova M, Eymard B, et al. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor. J Clin Invest 1994;94:555-559.
24. Harrison R, Lunt GG, Morris H, Savage Marengo T. Patient-specific anti-acetylcholine receptor antibody patterns in myasthenia gravis. Ann NY Acad Sci 1981;377:332-341.
25. Vernet-der Garabedian B, Eymard B, Bach JF, Morel E. Alpha-bungarotoxin blocking antibodies in neonatal myasthenia gravis: frequency and selectivity. J Neuroimmunol 1989; 21:41-47.
26. Tzartos SJ, Cung MT, Demange P, et al. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies. Mol Neurobiol 1991;5:1-29.
27. Graus Y, Meng F, Vincent A, van Breda Vriesman P, deBaets M. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis. J Immunol 1995;154: 6382-6396.
28. Geuder KI, Marx A, Witzemann V, et al. Pathogenic significance of fetal-type acetylcholine receptors on thymic myoid cells in myasthenia gravis. Dev Immunol 1992;2:69-75.
29. O'Malley JP, Wilson SJ, Bray JJ. Loss of antigenic properties of acetylcholine receptors in rat skeletal muscle after birth. J Neuroimmunol 1988;18:187-196.
30. Hall ZW, Gorin PD, Silberstein S, Bennett C. A postnatal change in the immunological properties of the acetylcholine receptors at rat muscle endplates. J Neurosci 1985;5:730-734.
31. Hesselmans LF, Jennekens FG, Van Den Oord CJ, Veldman H, Vincent A. Immunoreactivity to fetal acetylcholine receptor disappears during the 33rd week of human fetal development and reappears with denervation. Presented at the Second European Conference on Myasthenia Gravis, June 12, 1989, Tremezzo.